BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30197343)

  • 1. Evaluation of the photon dose calculation accuracy in radiation therapy of malignant pleural mesothelioma.
    Mahmoudi G; Farhood B; Shokrani P; Amouheidari A; Atarod M
    J Cancer Res Ther; 2018; 14(5):1029-1035. PubMed ID: 30197343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensity-Modulated Radiation Therapy Improves the Target Coverage Over 3-D Planning While Meeting Lung Tolerance Doses for All Patients With Malignant Pleural Mesothelioma.
    Ulger S; Cetin E; Catli S; Sarac H; Kilic D; Bora H
    Technol Cancer Res Treat; 2017 Jun; 16(3):332-338. PubMed ID: 28462689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the dose calculation accuracy in intensity-modulated radiation therapy for mesothelioma, focusing on low doses to the contralateral lung.
    Court LE; Ching D; Schofield D; Czerminska M; Allen AM
    J Appl Clin Med Phys; 2009 Apr; 10(2):34-42. PubMed ID: 19458589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compensator-based intensity-modulated radiation therapy for malignant pleural mesothelioma post extrapleural pneumonectomy.
    Javedan K; Stevens CW; Forster KM
    J Appl Clin Med Phys; 2008 Oct; 9(4):98-109. PubMed ID: 19020484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tomotherapy improves local control and changes failure patterns in locally advanced malignant pleural mesothelioma.
    Kishan AU; Cameron RB; Wang PC; Alexander S; Qi SX; Low DA; Kupelian PA; Steinberg ML; Lee JM; Selch MT; Lee P
    Pract Radiat Oncol; 2015; 5(6):366-73. PubMed ID: 26432677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study of volumetric-modulated arc therapy for malignant pleural mesothelioma.
    Runxiao L; Yankun C; Lan W
    J Appl Clin Med Phys; 2016 Mar; 17(2):139-144. PubMed ID: 27074478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of radical radiotherapy in the management of malignant pleural mesothelioma: A systematic review.
    Ashton M; O'Rourke N; Currie S; Rimner A; Chalmers A
    Radiother Oncol; 2017 Oct; 125(1):1-12. PubMed ID: 28859932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure patterns after hemithoracic pleural intensity modulated radiation therapy for malignant pleural mesothelioma.
    Rimner A; Spratt DE; Zauderer MG; Rosenzweig KE; Wu AJ; Foster A; Yorke ED; Adusumilli P; Rusch VW; Krug LM
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):394-401. PubMed ID: 25073664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of accuracy of out-of-field dose calculations by TiGRT treatment planning system in radiotherapy.
    Bahreyni Toossi MT; Soleymanifard S; Farhood B; Mohebbi S; Davenport D
    J Cancer Res Ther; 2018; 14(3):634-639. PubMed ID: 29893331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of a GEANT4-based Monte Carlo Model of a 0.35 T MR-guided radiation therapy (MRgRT) linear accelerator.
    Khan AU; Simiele EA; Lotey R; DeWerd LA; Yadav P
    Med Phys; 2021 Apr; 48(4):1967-1982. PubMed ID: 33555052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart Dosimetry is Correlated With Risk of Radiation Pneumonitis After Lung-Sparing Hemithoracic Pleural Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma.
    Yorke ED; Jackson A; Kuo LC; Ojo A; Panchoo K; Adusumilli P; Zauderer MG; Rusch VW; Shepherd A; Rimner A
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):61-69. PubMed ID: 28816162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy.
    Krayenbuehl J; Oertel S; Davis JB; Ciernik IF
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1593-9. PubMed ID: 17931793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-modulated radiotherapy and volumetric-modulated arc therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy.
    Krayenbuehl J; Riesterer O; Graydon S; Dimmerling P; Kloeck S; Ciernik IF
    J Appl Clin Med Phys; 2013 Jul; 14(4):4130. PubMed ID: 23835378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric verification of lung phantom calculated by collapsed cone convolution: A Monte Carlo and experimental evaluation.
    Najafzadeh M; Nickfarjam A; Jabbari K; Markel D; Chow JCL; Takabi FS
    J Xray Sci Technol; 2019; 27(1):161-175. PubMed ID: 30614811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated radiotherapy for relapsed malignant pleural mesothelioma.
    Spatola C; Militello C; Tocco A; Salamone V; Raffaele L; Migliore M; Pagana A; Milazzotto R; Chillura I; Pergolizzi S; Privitera G
    Future Oncol; 2016 Dec; 12(23s):67-71. PubMed ID: 27651129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant Pleural Mesothelioma: A Multi-Disciplinary Approach.
    Mansha MA; Ali N; Ali S; Azam N; Khan AMH
    Gulf J Oncolog; 2019 May; 1(30):76-80. PubMed ID: 31242986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.
    Patel PR; Yoo S; Broadwater G; Marks LB; Miles EF; D'Amico TA; Harpole D; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):362-8. PubMed ID: 22516382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose irradiation after pleurectomy/decortication or biopsy for pleural mesothelioma treatment.
    Parisi E; Romeo A; Sarnelli A; Ghigi G; Bellia SR; Neri E; Micheletti S; Dipalma B; Arpa D; Furini G; Burgio MA; Genestreti G; Gurioli C; Sanna S; Bovolato P; Rea F; Storme G; Scarpi E; Arienti C; Tesei A; Polico R
    Cancer Radiother; 2017 Dec; 21(8):766-773. PubMed ID: 29132803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External beam patient dose verification based on the integral quality monitor (IQM
    Mahuvava C; Du Plessis FCP
    Biomed Phys Eng Express; 2020 Mar; 6(3):035014. PubMed ID: 33438659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Monte Carlo evaluation of dose distribution of commercial treatment planning systems in heterogeneous media.
    Hasani M; Mohammadi K; Ghorbani M; Gholami S; Knaup C
    J Cancer Res Ther; 2019 Mar; 15(Supplement):S127-S134. PubMed ID: 30900634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.